Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)
All News about Theravance Biopharma, Inc. - Ordinary Shares
Via Benzinga
Theravance Biopharma Finally Shelves Failed JAK Inhibitor Program, Lays Off Staff ↗
February 28, 2023
Via Benzinga
Theravance Outlines $250M Capital Return Program; To Repurchase GSK's Entire Holdings ↗
September 19, 2022
Via Benzinga
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free